SDS

Chongqing Shandongshui Blood Purification Technology Joint-stock Co., Ltd. (hereinafter referred to as "SDS Company") was established in 2001. It is a national high-tech enterprise integrating blood purification equipment, blood purification consumables, hemodialysis center intelligent management systems, and chain hemodialysis centers, providing overall solutions for blood purification to global patients with kidney diseases and critical illnesses. SDS Company is a leading enterprise in China's blood purification industry, a drafting unit of national and industry standards, and the first enterprise in China's blood purification industry to be listed on the STAR Market ("SDS", stock code: 688410). Its subsidiaries include the wholly-owned Chongqing Tiantiantian Biotechnology Co., Ltd., Chongqing Kangmeijia Hemodialysis Co., Ltd., etc., as well as the Sino-Swiss joint venture Delaf (Chongqing) Medical Devices Co., Ltd. SDS Company adheres to an innovation-driven development strategy and has national-level platforms such as "National Enterprise Technology Center", "National Engineering Research Center", and "National Postdoctoral Research Station". It has received awards including the "Second Prize of National Science and Technology Progress Award" and has been rated as a "National Technology Innovation Demonstration Enterprise". The company has passed ISO13485:2016 quality management system certification, and its products have obtained EU CE certification, ensuring stable and reliable quality. Based on core key technologies of original blood purification equipment, SDS independently developed continuous renal replacement therapy (CRRT) equipment, hemodialysis machines, hemoperfusion machines, as well as consumables such as dialyzers, dialysate filters, dialysis tubing, hemoperfusion cartridges, and dialysis powder/liquid. These products are widely used clinically to treat acute and chronic renal failure, uremia, poisoning, multiple organ failure, and other critical conditions. All product series have been selected into the catalog of "Excellent Domestic Medical Device Product Selection". SDS products have been sold to thousands of medical institutions domestically and internationally, including major large tertiary hospitals such as the PLA General Hospital, Shanghai Jiao Tong University Affiliated Hospital, Zhujiang Hospital of Southern Medical University, Qilu Hospital of Shandong University, and the Second Xiangya Hospital of Central South University. They are also exported to more than 100 countries and regions worldwide, including Italy, Greece, Spain, Malaysia, India, and South Africa, with tens of thousands of installed units serving hundreds of thousands of kidney patients globally.